8家企业进入千亿市值俱乐部。《投资者网》蔡俊重新在上行周期的创新药行业，进入上市公司密集发布三季报的时间。从市值与业绩表现看，迈入千亿市值的创新药企呈现不同格局。老牌药企有成功转型，也有在摸着石头过河。新兴药企的龙头打通盈利闭环，也有还在“烧钱”阶段。无论如何，资本市场的热闹再现了“A+H”两地上市机遇。这次的创新药风暴，标志着国产创新药从“政策驱动的复苏期”一跃迈入“价值驱动的成长期”。过去，...
Source Link8家企业进入千亿市值俱乐部。《投资者网》蔡俊重新在上行周期的创新药行业，进入上市公司密集发布三季报的时间。从市值与业绩表现看，迈入千亿市值的创新药企呈现不同格局。老牌药企有成功转型，也有在摸着石头过河。新兴药企的龙头打通盈利闭环，也有还在“烧钱”阶段。无论如何，资本市场的热闹再现了“A+H”两地上市机遇。这次的创新药风暴，标志着国产创新药从“政策驱动的复苏期”一跃迈入“价值驱动的成长期”。过去，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.